USPTO serial 98087704
TEMPUS AI
Reviewed by CopyMark Law Group
Status 733Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- BROWN, TINA
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with TEMPUS AI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $772*
Plus Government fees of $375
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
CHICAGO, IL, US
Chicago, IL, US
CHICAGO, IL, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Amanda H. Wilcox
Amanda H. Wilcox TAFT STETTINIUS & HOLLISTER LLP200 Public Square, Suite 3500Cleveland, OH 44114United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable and recorded computer software using artificial intelligence for machine learning to support clinical data platforms for diagnostics in the fields of cardiology, electrophysiology, oncology, neurology, and mental health; downloadable and recorded computer software using artificial intelligence for machine learning for supporting clinical data platforms for cardiac diagnostics and electrophysiology | ACTIVE | — |
| 042 | Platform as a service (PAAS) featuring computer software platforms for medical access to patient health information; Providing a web site featuring technology that enables users to access patient health information; Software as a service (SAAS) services featuring software for medical access to patient health information; Platform as a service (PaaS) featuring computer software platforms for voice command and recognition software, speech to text conversion software, and voice-enabled software applications for information management in the field of electronic health records relating to oncology, cardiology, neurology, and mental health; Providing temporary use of online non-downloadable computer software for analyzing health information in support of making clinical decisions in the medical field; Platform as a service (PAAS) featuring computer software platforms using artificial intelligence for health information analysis in support of making clinical decisions in the medical field; Providing a web site featuring technology that enables users to use artificial intelligence for health information analysis in support of making clinical decisions in the medical field; Software as a service (SAAS) services featuring software using artificial intelligence for health information analysis in support of making clinical decisions in the medical field; Platform as a service (PAAS) featuring computer software platforms using artificial intelligence for cardiology health information analysis in support of making clinical decisions in the medical field; Providing a web site featuring technology that enables users to use artificial intelligence for cardiology health information analysis in support of making clinical decisions in the medical field; Software as a service (SAAS) services featuring software using artificial intelligence for cardiology health information analysis in support of making clinical decisions in the medical field; Platform as a service (PAAS) featuring computer software platforms using artificial intelligence for analyzing electrocardiographs and electrocardiograms in support of making clinical decisions in the medical field; Providing a web site featuring technology that enables users to use artificial intelligence for analyzing electrocardiographs and electrocardiograms in support of making clinical decisions in the medical field; Software as a service (SAAS) services featuring software using artificial intelligence for analyzing electrocardiographs and electrocardiograms in support of making clinical decisions in the medical field; Medical research; Medical and scientific research in the fields of genomics, genomic sequencing and genomic analysis; Software as a Service (SaaS) services featuring software for the review and analysis of medical images in the fields of radiology and pathology that provides actionable insights to add clinical value, improve diagnostic decision making, efficiency, and productivity, in the fields of oncology, cardiology, neurology, and mental health; medical and scientific research in the fields of diabetes, cardiology, neurology, oncology, electrophysiology, and mental health; providing medical and scientific research information in the fields of diabetes, cardiology, neurology, oncology, electrophysiology, and mental health; medical and scientific research and development services in the fields of cardiology, neurology, oncology, electrophysiology, and mental health; computer system design and analysis for use in cardiology, neurology, oncology, electrophysiology, and mental health; software development for cardiac diagnostics and cardiology and electrophysiology; platform as a service (PAAS) services featuring computer software platforms for operating cardiology and electrophysiology clinical decision support; software as a service (SAAS) services featuring software for cardiology and electrophysiology clinical decision support; software as a service (SAAS) services featuring artificial intelligence and machine learning-enabled computer software supporting clinical data platforms for use in the fields of cardiology, neurology, oncology, electrophysiology, and mental health; platform as a service (PAAS) services featuring computer software platforms employing artificial intelligence and machine learning-enabled computer software supporting clinical data platforms for use in the fields of cardiology, neurology, oncology, electrophysiology, and mental health; providing a website featuring on-line non-downloadable software that enables users to analyze genome sequences for disease assessment, prediction of medical and clinical outcomes, medical and clinical research, and drug development; providing a website featuring on-line non-downloadable software that enables users to collect, organize, and store genetic and genomic information of medical patients for diagnosis and treatment assistance; database development services, namely, curating, managing and organizing data libraries of genomic and medical information for healthcare professionals in cloud computing application systems; software as a service (SAAS) services featuring software for genomic sequencing, genomic related data analysis, and data management for hospitals and research centers; clinical research in the field of genomics; Structural and functional analysis of genomes; computer system design for use in oncology, electrophysiology, cardiology, neurology, and mental health diagnostics and testing; software development for diagnostics and medical, clinical and research testing in the fields of oncology, electrophysiology, cardiology, neurology, and mental health diagnostics and testing; platform as a service (PAAS) services featuring computer software platforms for operating clinical decision support in the fields of diabetes, neurology, and mental health diagnostics and testing; software as a service (SAAS) services featuring software for clinical decision support in the fields of oncology, electrophysiology, cardiology, neurology, and mental health diagnostics and testing; platform as a service (PAAS) featuring computer software platforms for clinical decision support in the fields of oncology, electrophysiology, cardiology, neurology, and mental health diagnostics and testing | ACTIVE | — |
| 044 | Medical services; genetic and health information analysis and diagnostics for medical purposes; providing an Internet website portal featuring patient health information in the fields of oncology, electrophysiology, cardiology, neurology, and mental health; medical services in the fields of cardiology, electrophysiology, oncology, neurology, and mental health diagnostics and testing; providing medical diagnostic testing that analyzes patient samples and creates genomic data from the analysis | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by TEMPUS AI, INC.
- Other trademarks owned by Tempus Labs, Inc.
- Other trademarks owned by TEMPUS AI, INC.
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named TEMPUS AI
- Prosecution event EEXT explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 16, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 17, 2026 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jun 17, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 17, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 17, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 4, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 3, 2026 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Apr 3, 2026 | EXT4 | SOU EXTENSION 4 FILED | — |
| Apr 3, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 8, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 30, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Sep 30, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Sep 30, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 17, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 16, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Apr 16, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Apr 16, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 20, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 20, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 20, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 20, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 23, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 4, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 27, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 7, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 7, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 23, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 23, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 23, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 23, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 23, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 22, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 21, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 21, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 17, 2024 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Nov 28, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 28, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 28, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 21, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 21, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 21, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 18, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 15, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 20, 2023 | NWAP | NEW APPLICATION ENTERED | — |